<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="28262">Dimethylsulfoxide</z:chebi> (DMSO) is a solvent commonly used for the cryopreservation of autologous peripheral blood stem cells (APBSC) </plain></SENT>
<SENT sid="1" pm="."><plain>Side effects upon infusion of DMSO-cryopreserved APBSC mainly consist of <z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0002013'>emesis</z:hpo>, chills, rigors, and cardiovascular events, such as <z:e sem="disease" ids="C0079035" disease_type="Disease or Syndrome" abbrv="">bradyarrhythmia</z:e> or <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report the case of a patient who received DMSO-cryopreserved APBSC after myeloablative chemotherapy for a relapsing <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient developed a rare reaction during the infusion manifesting as <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical course during the reaction is described and an explanation of the possible causes is discussed </plain></SENT>
<SENT sid="5" pm="."><plain>This observation underlines the need for an adequate DMSO <z:mpath ids='MPATH_63'>depletion</z:mpath> to limit neurotoxicity or other adverse manifestations </plain></SENT>
</text></document>